Kymera Therapeutics, Inc. logo KYMR - Kymera Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 24
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $138.20 DETAILS
HIGH: $180.00
LOW: $97.00
MEDIAN: $139.00
CONSENSUS: $138.20
UPSIDE: 22.95%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3
Revenue
Revenue 65 34.4 2.9 2.8 11.5 22.1 7.4 3.7 25.6 10.3 47.9 4.7 16.5 9.5 16.1 9.6 11.5 9.6 15.3 20.3 18.5 18.7 12.8 14.5 3.3 3.4 1.8 0.9
Cost of Revenue 0 0 (76.2) 74.1 2.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 65 34.4 79.0 (71.3) 9.4 22.1 7.4 3.7 25.6 10.3 47.9 4.7 16.5 9.5 16.1 9.6 11.5 9.6 15.3 20.3 18.5 18.7 12.8 14.5 3.3 3.4 1.8 0.9
Operating Expenses
R&D Expenses 119.5 98.2 83.9 74.1 78.4 80.3 71.8 60.4 59.2 48.8 53.0 48.1 45.8 42.2 43.1 43.9 41.3 35.9 37.5 38.3 35.2 26.0 20.4 15.8 13.8 12.1 11.1 11.3
SG&A Expenses 21.1 20.4 16.9 17.3 17.6 16.3 16.3 15.5 17.4 14.4 14.2 14.1 14.1 12.6 11.6 10.6 11.0 10.6 11.7 10.7 8.0 5.9 5.2 6.8 3.7 2.6 2.5 1.5
Other Expenses 0 0 76.1 (70.2) (2.1) 0 0 0 0 4.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 140.6 118.5 176.9 21.2 93.9 96.5 88.1 75.9 76.6 68.1 67.2 62.2 59.9 54.8 54.8 54.4 52.3 46.6 49.3 49.0 43.2 31.9 25.6 22.6 17.5 14.7 13.6 12.8
Operating Income
Operating Income (75.6) (84.2) (97.9) (92.5) (84.6) (74.4) (80.8) (72.1) (50.9) (57.8) (19.3) (57.5) (43.4) (45.3) (38.6) (44.9) (40.8) (36.9) (34.0) (28.6) (24.7) (13.2) (12.8) (8.1) (14.2) (11.2) (11.8) (11.9)
Interest Expense 0.1 0.1 0.1 0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Interest Income 14.5 15.0 10.7 10.3 8.1 8.9 10.1 9.7 8.9 9.3 5.0 4.7 4.6 4.5 3.8 1.9 0.6 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.3 0.4
Profitability
EBITDA (59.1) (67.2) (85.2) (80.0) (74.4) (63.5) (68.7) (60.4) (40.1) (47.0) (13.4) (51.9) (37.9) (40.0) (34.0) (42.2) (39.5) (36.0) (33.2) (27.8) (24.1) (12.6) (12.2) (7.5) (13.6) (10.5) (11.1) (11.3)
EBIT (61.1) (69.2) (87.2) (82.2) (76.5) (65.5) (70.7) (62.4) (42.0) (48.5) (14.3) (52.8) (38.8) (40.9) (34.8) (43.0) (40.2) (36.6) (33.8) (28.5) (24.6) (13.1) (12.7) (8.0) (14.0) (10.9) (11.5) (11.4)
Income Before Tax (61.2) (69.2) (87.3) (82.2) (76.6) (65.6) (70.8) (62.5) (42.1) (48.6) (14.4) (52.9) (38.8) (40.9) (34.9) (43.0) (40.3) (36.7) (33.9) (28.6) (24.7) (13.1) (12.7) (8.0) (14.0) (10.9) (11.5) (11.4)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (61.2) (69.2) (87.0) (82.2) (76.6) (65.6) (70.8) (62.5) (42.1) (48.6) (14.4) (52.9) (38.8) (40.9) (34.9) (43.0) (40.3) (36.7) (33.9) (28.6) (24.7) (13.1) (12.7) (8.0) (14.0) (10.9) (11.5) (11.4)
Per Share Data
EPS (Basic) -0.62 -0.71 -0.98 -0.94 -0.95 -0.82 -0.88 -0.82 -0.58 -0.69 -0.25 -0.90 -0.67 -0.63 -0.59 -0.79 -0.77 -0.71 -0.66 -0.56 -0.55 -0.29 -0.29 -0.18 -0.32 -0.25 -0.26 -0.26
EPS (Diluted) -0.62 -0.71 -0.98 -0.94 -0.95 -0.82 -0.88 -0.82 -0.58 -0.69 -0.25 -0.90 -0.67 -0.63 -0.59 -0.79 -0.77 -0.71 -0.66 -0.56 -0.55 -0.29 -0.29 -0.18 -0.32 -0.25 -0.26 -0.26
Shares Outstanding 98.2 97.5 84.4 87.3 80.4 80.1 80.0 76.1 73.1 70.8 58.5 58.4 58.3 58.2 57.9 54.5 51.8 51.7 51.4 50.7 45.1 44.6 44.5 43.8 43.1 44.5 44.5 44.5
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2019 Q4
Current Assets
Cash & Cash Equivalents 124.5 144.1 357.0 112.9 335.8 90.0 120.3 110.7 67.6 93.5 110.0 81.1 52.4 50.2 68.4 155.7 76.9 33.7 48.0 156.8 84.9 53.1 31.0 54.6 61.0 76.0
Short-Term Investments 566.5 506.8 491.3 392.7 329.6 373.2 368.5 439.3 442.3 427.0 264.9 276.8 315.2 346.7 338.8 326.2 315.4 387.1 394.4 379.6 274.2 280.4 265.2 239.2 95.0 15.9
Net Receivables 20 0 0 0 40 20 0.9 1.3 1.7 2.0 18.8 3.8 4.1 3.3 2.5 2.9 2.4 1.3 0.1 1.6 0.9 1.7 1.4 0.6 0 0
Inventory (5.8) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 5.8 26.5 22.9 22.6 22.9 17.8 20.6 17.4 13.8 14.7 11.7 14.1 13.7 11.4 9.7 0 0.0 0 0 0 0 0 0 0 0 0
Total Current Assets 737.3 677.4 871.2 528.3 728.3 501.0 510.3 568.7 525.4 537.3 405.3 375.7 385.4 411.6 419.4 494.0 402.8 431.4 451.3 543.7 364.8 340.8 302.3 297.4 158.3 92.8
Non-Current Assets
Property, Plant & Equipment 81.1 83.4 85.5 88.1 94.6 95.9 97.9 99.3 100.4 98.7 101.1 91.1 83.2 74.0 22.2 21.6 21.9 21.1 21.3 21.7 21.8 20.5 20.7 20.9 20.3 22.1
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 813.9 894.7 777.0 478.8 303.4 312.3 362.2 361.0 192.4 224.4 61.4 77.0 104.8 119.0 152.3 113.7 90.2 102.5 125.2 74.7 45.3 101.6 162.5 187.5 0 0
Other Non-Current Assets 7.0 13.5 9.1 6.8 4.7 9.1 7.7 5.8 7.7 7.9 7.9 8.6 8.6 9.3 9.1 9.1 8.5 8.1 8.1 2.3 2.5 1.6 1.6 1.6 2.5 1.8
Total Non-Current Assets 902 991.6 871.6 573.7 402.7 417.4 467.8 466.1 300.6 331.0 170.4 176.7 196.5 202.4 183.7 144.4 120.7 131.7 154.6 98.7 69.6 123.8 184.8 210.0 22.8 23.9
Total Assets 1,645.4 1,669.0 1,742.8 1,102.0 1,131.1 918.3 978.0 1,034.8 826.0 868.3 575.8 552.4 581.9 613.9 603.1 638.5 523.4 563.1 605.9 642.5 434.4 464.6 487.2 507.4 181.1 116.7
Current Liabilities
Account Payables 8.9 12.8 4.0 5.5 5.8 10.3 6.0 6.5 6.5 6.8 7.1 5.0 3.7 6.5 4.3 6.3 2.4 2.6 4.0 5.0 8.2 8.3 4.4 4.0 4.0 3.3
Short-Term Debt 0 0 13.8 13.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 22.9 23.3 40 11.5 13.6 20.0 19.3 22.6 37.9 27.4 24.3 32.2 35.3 55.8 59.5 60.9 61.7 66.2 82.3 87.9 92.6 92.0 27.3 23.3
Other Current Liabilities 0.2 1.0 24.2 17.3 20.6 0.9 0.2 17.6 0.2 0.8 0.5 0.9 0.3 0.8 0.3 0.7 0.3 0.6 0.2 0.4 0.1 0.3 0.1 0.7 0 0
Total Current Liabilities 75.0 62.6 83.2 71.6 87.5 59.0 67.8 66.5 62.1 56.1 85.7 63.2 54.6 61.9 71.3 91.1 87.5 88.3 92.5 94.5 108.7 110.1 110.6 107.3 42.7 34.6
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0.0 0.2 0.2 0.2 0.3 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0 0 109.1
Total Non-Current Liabilities 64.9 66.7 79.9 84.2 72.0 73.1 74.6 75.4 79.0 100.9 95.1 93.7 91.9 90.0 41.6 34.5 38.0 46.0 53.7 64.8 67.6 79.2 92.7 105.4 34.4 156.5
Total Liabilities 139.9 129.4 163.1 155.8 159.6 132.1 142.4 141.9 141.1 157.0 180.8 156.8 146.5 151.9 113.0 125.6 125.5 134.3 146.3 159.3 176.3 189.3 203.3 212.7 77.1 191.1
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (1,196.4) (1,135.2) (1,066.0) (979.0) (896.8) (820.2) (754.6) (683.9) (621.4) (579.3) (530.8) (516.4) (463.5) (424.7) (383.8) (348.9) (305.9) (265.7) (229.0) (195.1) (166.5) (141.8) (128.8) (116.1) (108.1) (76.5)
Accumulated Other Comprehensive Income (7.2) (4.2) 1.8 1.5 0.3 (0.1) (1.5) 1.9 (2.1) (1.8) (0.6) (2.5) (3.6) (3.0) (4.9) (5.9) (4.0) (3.2) (0.7) (0.1) 0 (0.0) (0.1) (0.2) 0.0 0.0
Total Stockholders' Equity 1,509.3 1,539.6 1,579.7 946.3 971.5 786.2 835.6 892.9 684.9 711.2 395.0 395.5 435.4 462.0 490.2 512.9 398.0 428.7 459.6 483.1 258.1 275.2 283.9 294.7 104.0 (74.4)
Total Liabilities & Equity 1,649.1 1,669.0 1,742.8 1,102.0 1,131.1 918.3 978.0 1,034.8 826.0 868.3 575.8 552.4 581.9 613.9 603.1 638.5 523.4 563.1 605.9 642.5 434.4 464.6 487.2 507.4 181.1 116.7
Debt Metrics
Total Debt 82.2 80.5 82.3 84.0 85.7 86.3 87.8 88.2 88.2 87.0 84.7 80.8 75.1 68.8 17.3 16.7 17.3 17.5 18.0 18.4 18.3 17.5 18.0 17.8 19.1 21.2
Net Debt (42.3) (63.6) (274.8) (29.0) (250.1) (3.6) (32.5) (22.5) 20.6 (6.5) (25.3) (0.2) 22.7 18.6 (51.1) (138.9) (59.6) (16.3) (30.0) (138.4) (66.6) (35.6) (13.0) (36.8) (41.9) (54.8)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3
Operating Activities
Net Income (61.2) (69.2) (87.0) (82.2) (76.6) (65.6) (70.8) (62.5) (42.1) (48.6) (14.4) (52.9) (38.8) (40.9) (34.9) (43.0) (40.3) (36.7) (33.9) (28.6) (24.7) (13.1) (12.7) (8.0) (14.0) (10.9) (11.5) (11.4)
Depreciation & Amortization 2.0 2.0 2.0 2.1 2.1 2.0 2.0 2.0 1.9 1.5 0.9 0.9 0.9 0.9 0.8 0.8 0.7 0.7 0.7 0.7 0.6 0.5 0.5 0.5 0.4 0.4 0.4 0.2
Stock-Based Compensation 18.9 16.0 14.5 15.8 15.4 14.2 13.8 14.9 14.3 12.0 10.9 11.7 11.2 9.4 8.9 9.1 9.6 7.9 8.7 7.4 5.7 3.2 1.8 2.3 0.7 0.4 0.3 0.2
Change in Working Capital (11.5) (34.9) 5.8 38.5 1.4 (27.3) 3.4 1.4 10.8 1.9 (0.5) 9.8 8.0 (8.1) 2.2 1.4 (0.2) (13.3) (15.5) (18.4) (13.4) (14.7) (11.3) 136.7 1.4 (2.0) (0.1) (1.6)
Other Non-Cash Items (2.3) (2.7) (2.0) (1.4) (2.1) (2.5) (10.2) (6.0) (27.9) (6.3) 11.1 (1.1) (16.5) (5.3) (16.6) (2.6) (8.9) 1.2 1.6 1.7 1.2 1.3 1.6 0.1 0.1 0.1 0.1 0.1
Operating Cash Flow (54.1) (88.8) (66.7) (27.1) (59.9) (79.2) (61.8) (50.2) (42.9) (39.6) 8.0 (31.6) (35.3) (44.0) (39.5) (34.3) (39.0) (40.3) (38.4) (37.3) (30.5) (22.8) (20.1) 131.7 (11.4) (12.1) (10.8) (12.5)
Investing Activities
Capital Expenditure (0.5) (0.4) (0.1) (0.2) (0.7) (0.5) (0.9) 0.2 (4.7) (7.4) (11.6) (8.1) (10.8) (4.0) (0.4) (1.2) (0.7) (0.5) (0.5) (0.3) (0.6) (0.2) (1.4) (2.4) (3.9) (1.4) (0.2) (0.2)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.2 5.8 0 0 1.3 0 0 0 0 0 0
Purchases of Investments (114.7) (276.3) (498.2) 0 (58.3) (83.7) 0 0 0 0 0 0 0 0 0 0 0 (80.1) (164.4) (245.8) (30.2) (16.0) (68.4) (350.4) (74.5) (36.0) 62.2 (78.1)
Sales/Maturities of Investments 135.2 131.1 101.8 0 116.8 130.2 0 0 0 0 0 0 0 0 0 0 0 106.5 96.9 109.3 91.5 60.5 65.9 18.5 31.5 0 0 0
Other Investing Activities 0 2.7 2.0 (235.1) 2.1 2.5 69.5 (157.9) 20.3 (323.2) 30.6 68.6 46.6 28.6 (49.3) (36.2) 82.5 (1.2) (5.8) 0 0 (1.3) 0 0 0 0 0 0
Investing Cash Flow 20.0 (142.8) (394.4) (235.3) 60.0 48.6 68.6 (157.7) 15.6 (330.6) 19.0 60.5 35.8 24.6 (49.7) (37.5) 81.8 25.9 (68.0) (136.9) 60.7 44.3 (4.0) (334.3) (46.9) (37.4) 62.0 (78.3)
Financing Activities
Net Debt Issuance (0.9) (0.4) (0.4) (0.4) (0.4) (0.3) (0.3) (0.6) (0.4) (0.3) 0.9 (0.3) (0.3) (0.3) (0.3) (0.3) (0.3) (0.3) (0.2) (0.4) (0.2) (0.2) (0.2) (0.1) (0.2) (0.1) (0.1) (0.1)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.4 0 0 39.9 0 0 3.1 251.6 1.8 354.0 1.0 0.1 1.6 1.5 2.3 150.8 0.6 0.4 2.2 246.4 1.8 0.8 0.0 196.4 0.0 0 0.0 0.0
Financing Cash Flow 14.4 18.8 705.2 39.5 245.7 0.3 2.8 250.9 1.4 353.8 1.9 (0.2) 1.3 1.2 2.0 150.5 0.4 0.2 2.1 246.0 1.6 0.6 0.3 196.3 (0.4) 93.1 21.1 (0.0)
Cash Position
Net Change in Cash (19.6) (212.9) 244.1 (222.9) 245.9 (30.3) 9.5 43.0 (25.9) (16.4) 28.9 28.7 1.9 (18.2) (87.2) 78.7 43.2 (14.2) (104.3) 71.9 31.8 22.1 (23.8) (6.4) (58.7) 43.7 72.3 (90.8)
Cash at Beginning 149.9 362.8 118.7 341.6 95.8 126.0 116.5 73.5 99.3 115.8 86.8 58.2 56.3 74.5 161.8 83.0 39.8 54.1 158.4 86.5 54.7 32.6 56.4 62.8 121.4 77.8 5.5 96.4
Cash at End 130.3 149.9 362.8 118.7 341.6 95.8 126.0 116.5 73.5 99.3 115.8 86.8 58.2 56.3 74.5 161.8 83.0 39.8 54.1 158.4 86.5 54.7 32.6 56.4 62.8 121.4 77.8 5.5
Free Cash Flow (54.5) (89.3) (66.9) (27.3) (60.6) (79.6) (62.7) (50.0) (47.6) (47.0) (3.6) (39.7) (46.0) (48.0) (39.9) (35.5) (39.7) (40.8) (38.9) (37.6) (31.1) (23.0) (21.5) 129.3 (15.3) (13.5) (11) (12.7)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3
Income Statement
Revenue 65 34.4 2.9 2.8 11.5 22.1 7.4 3.7 25.6 10.3 47.9 4.7 16.5 9.5 16.1 9.6 11.5 9.6 15.3 20.3 18.5 18.7 12.8 14.5 3.3 3.4 1.8 0.9
Gross Profit 65 34.4 79.0 (71.3) 9.4 22.1 7.4 3.7 25.6 10.3 47.9 4.7 16.5 9.5 16.1 9.6 11.5 9.6 15.3 20.3 18.5 18.7 12.8 14.5 3.3 3.4 1.8 0.9
Operating Income (75.6) (84.2) (97.9) (92.5) (84.6) (74.4) (80.8) (72.1) (50.9) (57.8) (19.3) (57.5) (43.4) (45.3) (38.6) (44.9) (40.8) (36.9) (34.0) (28.6) (24.7) (13.2) (12.8) (8.1) (14.2) (11.2) (11.8) (11.9)
Net Income (61.2) (69.2) (87.0) (82.2) (76.6) (65.6) (70.8) (62.5) (42.1) (48.6) (14.4) (52.9) (38.8) (40.9) (34.9) (43.0) (40.3) (36.7) (33.9) (28.6) (24.7) (13.1) (12.7) (8.0) (14.0) (10.9) (11.5) (11.4)
EPS (Diluted) -0.62 -0.71 -0.98 -0.94 -0.95 -0.82 -0.88 -0.82 -0.58 -0.69 -0.25 -0.90 -0.67 -0.63 -0.59 -0.79 -0.77 -0.71 -0.66 -0.56 -0.55 -0.29 -0.29 -0.18 -0.32 -0.25 -0.26 -0.26
Balance Sheet
Cash & Equivalents 124.5 144.1 357.0 112.9 335.8 90.0 120.3 110.7 67.6 93.5 110.0 81.1 52.4 50.2 68.4 155.7 76.9 33.7 48.0 156.8 84.9 53.1 31.0 54.6 61.0 76.0
Total Assets 1,645.4 1,669.0 1,742.8 1,102.0 1,131.1 918.3 978.0 1,034.8 826.0 868.3 575.8 552.4 581.9 613.9 603.1 638.5 523.4 563.1 605.9 642.5 434.4 464.6 487.2 507.4 181.1 116.7
Total Debt 82.2 80.5 82.3 84.0 85.7 86.3 87.8 88.2 88.2 87.0 84.7 80.8 75.1 68.8 17.3 16.7 17.3 17.5 18.0 18.4 18.3 17.5 18.0 17.8 19.1 21.2
Stockholders' Equity 1,509.3 1,539.6 1,579.7 946.3 971.5 786.2 835.6 892.9 684.9 711.2 395.0 395.5 435.4 462.0 490.2 512.9 398.0 428.7 459.6 483.1 258.1 275.2 283.9 294.7 104.0 (74.4)
Cash Flow
Operating Cash Flow (54.1) (88.8) (66.7) (27.1) (59.9) (79.2) (61.8) (50.2) (42.9) (39.6) 8.0 (31.6) (35.3) (44.0) (39.5) (34.3) (39.0) (40.3) (38.4) (37.3) (30.5) (22.8) (20.1) 131.7 (11.4) (12.1) (10.8) (12.5)
Capital Expenditure (0.5) (0.4) (0.1) (0.2) (0.7) (0.5) (0.9) 0.2 (4.7) (7.4) (11.6) (8.1) (10.8) (4.0) (0.4) (1.2) (0.7) (0.5) (0.5) (0.3) (0.6) (0.2) (1.4) (2.4) (3.9) (1.4) (0.2) (0.2)
Free Cash Flow (54.5) (89.3) (66.9) (27.3) (60.6) (79.6) (62.7) (50.0) (47.6) (47.0) (3.6) (39.7) (46.0) (48.0) (39.9) (35.5) (39.7) (40.8) (38.9) (37.6) (31.1) (23.0) (21.5) 129.3 (15.3) (13.5) (11) (12.7)